LGVN Longeveron Inc.
Healthcare$0.82+13.74%ClosedMarket Cap: $17.9M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
1.27
P/S
14.69
EV/EBITDA
-0.13
DCF Value
$-1.37
FCF Yield
-104.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
65.1%
Operating Margin
-1881.7%
Net Margin
-1844.5%
ROE
-202.4%
ROA
-105.7%
ROIC
-130.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $398.0K | 66.3% | $-4.8M | $-4.7M | $— | — |
| Q4 null | $365.0K | 70.4% | $-5.4M | $-5.4M | $— | — |
| FY null | $1.2M | 67.0% | $-23.3M | $-22.7M | $— | — |
| Q3 null | $137.0K | 91.2% | $-7.3M | $-7.2M | $— | — |
| Q2 null | $316.0K | 46.2% | $-5.4M | $-5.0M | $— | — |
| Q1 null | $381.0K | 72.2% | $-5.2M | $-5.0M | $— | — |
| Q4 null | $603.0K | 87.9% | $-4.3M | $-4.1M | $— | — |
| FY null | $2.4M | 78.8% | $-16.5M | $-16.0M | $— | — |
| Q3 null | $773.0K | 88.2% | $-4.6M | $-4.4M | $— | — |
| Q2 null | $468.0K | 73.5% | $-3.5M | $-3.4M | $— | — |
| Q1 null | $548.0K | 60.0% | $-4.1M | $-4.1M | $— | — |
| Q4 2023 | $63.0K | -3.2% | $-5.4M | $-6.0M | $0.00 | — |